Glucocorticosteroids inhibit leukotriene production

I. Caroline Crocker, Chang Y. Zhou, Againdra K. Bewtra, William Kreutner, Robert G. Townley

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: The mode of action of corticosteroids, important drugs in the treatment of inflammatory disease, is not yet fully understood. Corticosteroids are known to inhibit phospholipase A2 in unprimed eosinophils and basophils, preventing leukotriene synthesis, but their effect on cells that are already primed is unknown. Objective: As inflammatory cells from atopic subjects are often primed in vivo, we studied the effects of two potent corticosteroids on basophil sulfidoleukotriene production in peripheral blood mixed leukocytes (PBML) from in-season and out-of-season atopic individuals. Methods: Cells were incubated for 24 hours with mometasone furoate or beclomethasone dipropionate, primed with IL-3, stimulated with calcium ionophore, buffer, allergen or anti-IgE, and leukotriene production was quantified. Results: Peripheral blood mononuclear leukocytes from five of ten donors (in season) produced elevated sulfidoleukotrienes without a stimulus; cells from seven donors responded to anti-IgE by increased sulfidoleukotrienes. Neither steroid consistently affected sulfidoleukotriene production in anti-IgE-stimulated cells which were releasing sulfidoleukotrienes in the absence of a stimulant. In comparison, sulfidoleukotriene production was significantly reduced by 0.01 to 10 nM beclomethasone dipropionate or mometasone furoate when the cells were primed with IL-3 after exposure to the drug and stimulated with calcium ionophore or allergen, but no dose-relationship was apparent. Leukotriene production by PBML in response to anti-IgE was potently inhibited by all concentrations of mometasone furoate (0.01 nM to I μM) with an inhibitory concentrations50 of less than 0.01 nM. Beclomethasone dipropionate inhibited sulfidoleukotriene production in this group (inhibitory concentration50 6 nM) in a dose-dependent manner. Conclusions: Sulfidoleukotriene production and, conceivably, priming may be more effectively inhibited by mometasone furoate than beclomethasone dipropionate.

Original languageEnglish
Pages (from-to)497-505
Number of pages9
JournalAnnals of Allergy, Asthma and Immunology
Volume78
Issue number5
StatePublished - May 1997

Fingerprint

Mometasone Furoate
Leukotrienes
Beclomethasone
Adrenal Cortex Hormones
Basophils
Calcium Ionophores
Interleukin-3
Allergens
Leukocytes
Mononuclear Leukocytes
Phospholipases A2
Eosinophils
Pharmaceutical Preparations
Buffers
Steroids
anti-IgE antibodies

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy

Cite this

Crocker, I. C., Zhou, C. Y., Bewtra, A. K., Kreutner, W., & Townley, R. G. (1997). Glucocorticosteroids inhibit leukotriene production. Annals of Allergy, Asthma and Immunology, 78(5), 497-505.

Glucocorticosteroids inhibit leukotriene production. / Crocker, I. Caroline; Zhou, Chang Y.; Bewtra, Againdra K.; Kreutner, William; Townley, Robert G.

In: Annals of Allergy, Asthma and Immunology, Vol. 78, No. 5, 05.1997, p. 497-505.

Research output: Contribution to journalArticle

Crocker, IC, Zhou, CY, Bewtra, AK, Kreutner, W & Townley, RG 1997, 'Glucocorticosteroids inhibit leukotriene production', Annals of Allergy, Asthma and Immunology, vol. 78, no. 5, pp. 497-505.
Crocker IC, Zhou CY, Bewtra AK, Kreutner W, Townley RG. Glucocorticosteroids inhibit leukotriene production. Annals of Allergy, Asthma and Immunology. 1997 May;78(5):497-505.
Crocker, I. Caroline ; Zhou, Chang Y. ; Bewtra, Againdra K. ; Kreutner, William ; Townley, Robert G. / Glucocorticosteroids inhibit leukotriene production. In: Annals of Allergy, Asthma and Immunology. 1997 ; Vol. 78, No. 5. pp. 497-505.
@article{ae4a6efc2e234661b08c2a1d7120fd93,
title = "Glucocorticosteroids inhibit leukotriene production",
abstract = "Background: The mode of action of corticosteroids, important drugs in the treatment of inflammatory disease, is not yet fully understood. Corticosteroids are known to inhibit phospholipase A2 in unprimed eosinophils and basophils, preventing leukotriene synthesis, but their effect on cells that are already primed is unknown. Objective: As inflammatory cells from atopic subjects are often primed in vivo, we studied the effects of two potent corticosteroids on basophil sulfidoleukotriene production in peripheral blood mixed leukocytes (PBML) from in-season and out-of-season atopic individuals. Methods: Cells were incubated for 24 hours with mometasone furoate or beclomethasone dipropionate, primed with IL-3, stimulated with calcium ionophore, buffer, allergen or anti-IgE, and leukotriene production was quantified. Results: Peripheral blood mononuclear leukocytes from five of ten donors (in season) produced elevated sulfidoleukotrienes without a stimulus; cells from seven donors responded to anti-IgE by increased sulfidoleukotrienes. Neither steroid consistently affected sulfidoleukotriene production in anti-IgE-stimulated cells which were releasing sulfidoleukotrienes in the absence of a stimulant. In comparison, sulfidoleukotriene production was significantly reduced by 0.01 to 10 nM beclomethasone dipropionate or mometasone furoate when the cells were primed with IL-3 after exposure to the drug and stimulated with calcium ionophore or allergen, but no dose-relationship was apparent. Leukotriene production by PBML in response to anti-IgE was potently inhibited by all concentrations of mometasone furoate (0.01 nM to I μM) with an inhibitory concentrations50 of less than 0.01 nM. Beclomethasone dipropionate inhibited sulfidoleukotriene production in this group (inhibitory concentration50 6 nM) in a dose-dependent manner. Conclusions: Sulfidoleukotriene production and, conceivably, priming may be more effectively inhibited by mometasone furoate than beclomethasone dipropionate.",
author = "Crocker, {I. Caroline} and Zhou, {Chang Y.} and Bewtra, {Againdra K.} and William Kreutner and Townley, {Robert G.}",
year = "1997",
month = "5",
language = "English",
volume = "78",
pages = "497--505",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "5",

}

TY - JOUR

T1 - Glucocorticosteroids inhibit leukotriene production

AU - Crocker, I. Caroline

AU - Zhou, Chang Y.

AU - Bewtra, Againdra K.

AU - Kreutner, William

AU - Townley, Robert G.

PY - 1997/5

Y1 - 1997/5

N2 - Background: The mode of action of corticosteroids, important drugs in the treatment of inflammatory disease, is not yet fully understood. Corticosteroids are known to inhibit phospholipase A2 in unprimed eosinophils and basophils, preventing leukotriene synthesis, but their effect on cells that are already primed is unknown. Objective: As inflammatory cells from atopic subjects are often primed in vivo, we studied the effects of two potent corticosteroids on basophil sulfidoleukotriene production in peripheral blood mixed leukocytes (PBML) from in-season and out-of-season atopic individuals. Methods: Cells were incubated for 24 hours with mometasone furoate or beclomethasone dipropionate, primed with IL-3, stimulated with calcium ionophore, buffer, allergen or anti-IgE, and leukotriene production was quantified. Results: Peripheral blood mononuclear leukocytes from five of ten donors (in season) produced elevated sulfidoleukotrienes without a stimulus; cells from seven donors responded to anti-IgE by increased sulfidoleukotrienes. Neither steroid consistently affected sulfidoleukotriene production in anti-IgE-stimulated cells which were releasing sulfidoleukotrienes in the absence of a stimulant. In comparison, sulfidoleukotriene production was significantly reduced by 0.01 to 10 nM beclomethasone dipropionate or mometasone furoate when the cells were primed with IL-3 after exposure to the drug and stimulated with calcium ionophore or allergen, but no dose-relationship was apparent. Leukotriene production by PBML in response to anti-IgE was potently inhibited by all concentrations of mometasone furoate (0.01 nM to I μM) with an inhibitory concentrations50 of less than 0.01 nM. Beclomethasone dipropionate inhibited sulfidoleukotriene production in this group (inhibitory concentration50 6 nM) in a dose-dependent manner. Conclusions: Sulfidoleukotriene production and, conceivably, priming may be more effectively inhibited by mometasone furoate than beclomethasone dipropionate.

AB - Background: The mode of action of corticosteroids, important drugs in the treatment of inflammatory disease, is not yet fully understood. Corticosteroids are known to inhibit phospholipase A2 in unprimed eosinophils and basophils, preventing leukotriene synthesis, but their effect on cells that are already primed is unknown. Objective: As inflammatory cells from atopic subjects are often primed in vivo, we studied the effects of two potent corticosteroids on basophil sulfidoleukotriene production in peripheral blood mixed leukocytes (PBML) from in-season and out-of-season atopic individuals. Methods: Cells were incubated for 24 hours with mometasone furoate or beclomethasone dipropionate, primed with IL-3, stimulated with calcium ionophore, buffer, allergen or anti-IgE, and leukotriene production was quantified. Results: Peripheral blood mononuclear leukocytes from five of ten donors (in season) produced elevated sulfidoleukotrienes without a stimulus; cells from seven donors responded to anti-IgE by increased sulfidoleukotrienes. Neither steroid consistently affected sulfidoleukotriene production in anti-IgE-stimulated cells which were releasing sulfidoleukotrienes in the absence of a stimulant. In comparison, sulfidoleukotriene production was significantly reduced by 0.01 to 10 nM beclomethasone dipropionate or mometasone furoate when the cells were primed with IL-3 after exposure to the drug and stimulated with calcium ionophore or allergen, but no dose-relationship was apparent. Leukotriene production by PBML in response to anti-IgE was potently inhibited by all concentrations of mometasone furoate (0.01 nM to I μM) with an inhibitory concentrations50 of less than 0.01 nM. Beclomethasone dipropionate inhibited sulfidoleukotriene production in this group (inhibitory concentration50 6 nM) in a dose-dependent manner. Conclusions: Sulfidoleukotriene production and, conceivably, priming may be more effectively inhibited by mometasone furoate than beclomethasone dipropionate.

UR - http://www.scopus.com/inward/record.url?scp=1842367341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842367341&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 497

EP - 505

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 5

ER -